Studies suggest possible future treatments to reverse Parkinson's

Scientists have found 'vital new evidence' towards halting the progression of Parkinson's disease, after an animal model study found that drugs could reverse problems arising from genetic defects.

MRI scan of a brain showing Parkinson's disease (Photo: Science Photo Library)
MRI scan of a brain showing Parkinson's disease (Photo: Science Photo Library)

Mutations in the LRRK2 gene in humans are known to be the most common genetic contributor to Parkinson’s disease, although the mechanisms have been poorly understood.

But in tests on in vitro rat neurons, University of Sheffield researchers found that these mutations interfere with how vital proteins and minerals are transported across nerve cells, causing impaired motor functions.

The study, published in Nature, also looked at fruit flies with faulty copies of the LRKK2 gene. It found that by targeting the transport system in these neurons with specific drugs, these defects could be reversed, thereby alleviating Parkinson’s disease-like symptoms in the flies.

'Rescue effect' for patients

The drugs, known as deacetylase inhibitors, work by restoring normal transport along the faulty neurons and therefore could have a ‘rescue effect’ in affected cells.

Study author Dr Alex Whitworth said: ‘By targeting the transport system with drugs, we could not only prevent movement problems, but also fully restore movement abilities in fruit flies who already showed impaired movement marked by a significant decrease in both climbing and flight ability.’

The authors concluded that the ‘very promising results’ show that drug treatments ‘may have therapeutic potential’ for treating humans with Parkinson’s, although much more research will be needed to see if the effects could be replicated outside of animal tests.

Dr Beckie Port, from Parkinson’s UK, which helped to fund the study, said: ‘This research gives hope that, for people with a particular mutation in their genes, it may one day be possible to intervene and stop the progression of Parkinson’s.’

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GP dilemma: What should I do if a parent sends their child with COVID-19 symptoms to school?

GP dilemma: What should I do if a parent sends their child with COVID-19 symptoms to school?

Medical Protection's Dr Clare Devlin offers advice on how GPs should respond to parents...

GPs risk missing out on vital COVID-19 risk assessments, BMA warns

GPs risk missing out on vital COVID-19 risk assessments, BMA warns

GPs risk missing out on COVID-19 risk assessments unless practices are guaranteed...

GPs call for partial suspension of network DES amid heavy workload

GPs call for partial suspension of network DES amid heavy workload

GPs leading primary care networks (PCNs) have called for the partial suspension of...

UK COVID-19 alert level raised as GPs prioritised for testing

UK COVID-19 alert level raised as GPs prioritised for testing

The government has raised the UK's COVID-19 alert level to four amid reports that...

UK on course for 50,000 COVID-19 cases a day by mid-October

UK on course for 50,000 COVID-19 cases a day by mid-October

The UK could see 50,000 COVID-19 cases per day by mid-October, with the epidemic...

Stricter short-term COVID-19 measures needed to avoid second national lockdown, BMA warns

Stricter short-term COVID-19 measures needed to avoid second national lockdown, BMA warns

COVID-19 infection rates will ‘soar’ and the NHS will ‘once again be crippled’ if...